Pardi, N. & Weissman, D. Development of vaccines and antivirals for combating viral pandemics. Nat. Biomed. Eng. 4, 1128–1133 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayouni, I. et al. Effective public health measures to mitigate the spread of COVID-19: A systematic review. BMC Public Health 21, 1015 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Andrei, G. Vaccines and antivirals: Grand challenges and great opportunities. Front. Virol. 1, 666548 (2021).

Article  Google Scholar 

Ma, Y. et al. Medicinal chemistry strategies for discovering antivirals effective against drug-resistant viruses. Chem. Soc. Rev. 50, 4514–4540 (2021).

Article  CAS  PubMed  Google Scholar 

Kausar, S. et al. A review: Mechanism of action of antiviral drugs. Int. J. Immunopath. Pharmacol. 35, 1–12 (2021).

Article  Google Scholar 

Karim, M., Lo, C. & Einav, S. Preparing for the next viral threat with broad-spectrum antivirals. J. Clin. Invest. 133, e170236 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kumari, R. et al. Antiviral approaches against influenza virus. Clin. Microbiol. Rev. 36, e00040–22 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Bian, L. et al. Effects of SARS-CoV-2 variants on vaccine efficacy and response strategies. Expert Rev. Vaccines 20, 365–373 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Demarest, J. F. et al. Antiviral target compound profile for pandemic preparedness. Nat. Rev. Drug Discov. 24, 151–152 (2025).

Article  CAS  PubMed  Google Scholar 

Vincent, F. et al. Phenotypic drug discovery: Recent successes, lessons learned and new directions. Nat. Rev. Drug Discov. 21, 899–914 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ayotte, Y. et al. Fragment-based phenotypic lead discovery to identify new drug seeds that target infectious diseases. ACS Chem. Biol. 16, 2158–2163 (2021).

Article  CAS  PubMed  Google Scholar 

Bolognesi, M. L. Polypharmacology in a single drug: Multitarget drugs. Curr. Med. Chem. 20, 1639–1645 (2013).

Article  CAS  PubMed  Google Scholar 

Wang, Y. et al. Therapeutic target database 2020: Enriched resource for facilitating research and early development of targeted therapeutics. Nucleic Acids Res. 48, D1031–D1041 (2019).

Google Scholar 

Santos, R. et al. A comprehensive map of molecular drug targets. Nat. Rev. Drug Discov. 16, 19–34 (2017).

Article  CAS  PubMed  Google Scholar 

Moffat, J. G., Vincent, F., Lee, J. A., Eder, J. & Prunotto, M. Opportunities and challenges in phenotypic drug discovery: An industry perspective. Nat. Rev. Drug Discov. 16, 531–543 (2017).

Article  CAS  PubMed  Google Scholar 

Szabo, M. et al. Cell and small animal models for phenotypic drug discovery. Drug Des. Dev. Ther. 11, 1957–1967 (2017).

Article  CAS  Google Scholar 

Sadri, A. Is target-based drug discovery efficient? Discovery and “off-target” mechanisms of all drugs. J. Med. Chem. 66, 12651–12677 (2023).

Article  CAS  PubMed  Google Scholar 

Malandraki-Miller, S. & Riley, P. R. Use of artificial intelligence to enhance phenotypic drug discovery. Drug Discov. Today 26, 887–901 (2021).

Article  PubMed  Google Scholar 

Yang, Y. et al. Discovery, optimization, and target identification of novel potent broad-spectrum antiviral inhibitors. J. Med. Chem. 62, 4056–4073 (2019).

Article  CAS  PubMed  Google Scholar 

Xie, X. et al. Recent advances in targeting the “undruggable” proteins: From drug discovery to clinical trials. Sig. Transduct. Tar. Ther. 8, 335 (2023).

Article  Google Scholar 

Gordillo-Marañón, M. et al. Disease coverage of human genome-wide association studies and pharmaceutical research and development. Commun. Med. 4, 195 (2024).

Article  PubMed  PubMed Central  Google Scholar 

Al-Ali, H. The evolution of drug discovery: From phenotypes to targets, and back. Med. Chem. Commun. 7, 788 (2016).

Article  CAS  Google Scholar 

Ren, F. et al. A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models. Nat. Biotechnol. 43, 63–75 (2025).

Article  CAS  PubMed  Google Scholar 

Du, S., Hu, X., Menéndez-Arias, L., Zhan, P. & Liu, X. Target-based drug design strategies to overcome resistance to antiviral agents: Opportunities and challenges. Drug Resistance Update 73, 101053 (2024).

Article  CAS  Google Scholar 

Li, G., Hilgenfeld, R., Whitley, R. & De Clercq, E. Therapeutic strategies for COVID-19: Progress and lessons learned. Nat. Rev. Drug Discov. 22, 449–475 (2023).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Oktavianawati, I., Santoso, M., Bakar, M. F. A., Kim, Y. U. & Fatmawati, S. Recent progress on drugs discovery study for treatment of COVID-19: Repurposing existing drugs and current natural bioactive molecules. Appl. Biol. Chem. 66, 89 (2023).

Article  Google Scholar 

Chan, J. F. W., Yuan, S., Chu, H., Sridhar, S. & Yuen, K. Y. COVID-19 drug discovery and treatment options. Nat. Rev. Microbiol. 22, 391–407 (2024).

Article  CAS  PubMed  Google Scholar 

Ng, T. I. et al. Antiviral drug discovery for the treatment of COVID-19 infections. Viruses 14, 961 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Romasanta, A. K. S., Van Der Sijde, P. & Van Muijlwijk-Koezen, J. Innovation in pharmaceutical R&D: Mapping the research landscape. Scientometrics 125, 1801–1832 (2020).

Article  Google Scholar 

Stiller, I., Van Witteloostuijn, A. & Cambré, B. Determinants of radical drug innovation: A systematic literature review. Manag. Rev. Quart. 72, 967–1016 (2022).

Google Scholar 

Wu, K. et al. TamGen: Drug design with target-aware molecule generation through a chemical language model. Nat. Commun. 15, 9360 (2024).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martin, M. P., Endicott, J. A., Noble, M. E. M. & Tatum, N. J. Crystallographic fragment screening in academic cancer drug discovery. Methods Enzymol. 690, 211–234 (2023).

Article  CAS  PubMed  Google Scholar 

Von Delft, F. et al. A white-knuckle ride of open COVID drug discovery. Nature 594, 330–332 (2021).

Article  Google Scholar 

Landis, M. N. Topical and intralesional antiviral agents. Topical and Intralesional Antiviral Agents 493–503 (2021).

Magri, A. et al. Rethinking the old antiviral drug moroxydine: Discovery of novel analogs as anti-hepatitis C virus (HCV) agents. Bioorg. Med. Chem. Lett. 25, 5372–5376 (2015).

Article  CAS  PubMed  Google Scholar 

Kathuria, D., Raul, A. D., Wanjari, P. & Bharatam, P. V. Biguanides: Species with versatile therapeutic applications. Eur. J. Med. Chem. 219, 113378 (2021).